Livongo Health, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Livongo Health, Inc.
The legal battle between Teladoc and Amwell heats up as the post-pandemic future of telehealth remains in question.
HLTH 2020: Teladoc And Livongo Say Clients, Doctors Excited About Merger, Cross-Selling Deal With Florida Blue
The CEOs of Teladoc and Livongo said the merged digital health giant will create one-stop shopping for health care.
Telehealth company Amwell priced its stock between $14 and $16 per share for its planned IPO and partnered with Google for its cloud services.
Post-COVID, a consumer’s home as point of care has led to greater acceptance for health gadgets while shifting preferences away from injectables, shows a new study, which has pointers for pharma strategy. With anxiety over the pandemic continuing, mental telehealth solutions are ripe for the picking.
- Digital Health
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Other Names / Subsidiaries
- myStrength Inc.
- Retrofit, Inc.